
X4 Pharmaceuticals, Inc.
USD4.23
+0.21 (+5.22%)
CEO
Adam R. Craig
IPO Date
2017-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.06
Prev. Close
$4.02
Day Low
$4.00
Day High
$4.25
52W Low
$1.35
52W High
$4.83
Market Cap
$0.40B
Volume
0.58M
X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström's Macroglobulinemia as Published in EHA Abstract